Alkyl-substituted cellulose-based sustained-release oral drug dosage forms
AssigneeDepomed, Inc.
InventorJohn W. Shell
Life of this patent
Estimating the term…
Loading patent…
AssigneeDepomed, Inc.
InventorJohn W. Shell
Estimating the term…
Sustained release oral drug dosage forms that comprise a tablet or capsule containing a plurality of particles of a solid-state drug dispersed in alkyl cellulose such as hydroxyethylcellulose or hydroxypropylcellulose. Once ingested the tablet or capsule disintegrates to disperse the particles into the stomach where they imbibe water to cause them to swell and also to become slippery, thus enhancing their retention in the stomach. Imbibed water from the gastric fluid dissolves the drug entrapped in the particles and the resulting solution diffuses from the dispersed particles, assuring that no solid drug, which with some drugs is more irritating, contacts the mucosal tissue. A number of embodiments of the dosage form utilizing different drugs are exemplified and the benefits are explained. Aspirin is one example.
A sustained release oral drug dosage form for releasing a solution of a drug into the stomach comprising a plurality of solid particles of initially about 3-9 mm in diameter in maximum dimension, each particle containing a solid-state drug dispersed within a non-chemically crosslinked alkyl-substituted cellulose selected from the group consisting of hydroxyethylcellulose, hydroxypropylcellulose, hydroxypropylmethylcellulose, carboxymethylcellulose, and hydroxymethylcellulose, in a weight ratio of drug to polymer of about 1:9 to 9:1, the particles (i) swelling unrestrained dimensionally up to about three times their original diameter via imbibition of water from gastric fluid to increase the size of the particles to promote retention within the stomach, and make the particles slippery, which also promotes their retention within the stomach, (ii) permitting dissolution of the dispersed drug by imbibed gastric water while the drug is within the particle and release of the resulting solution, thus assuring that only drug in solution contacts the gastric mucosa, (iii) protecting undissolved drug from stomach enzymes or pH and duodenum, and (iv) maintaining their physical integrity over at least a substantial portion of the time period during which the drug is released into the stomach and then dissolves;
Dependencies are inferred from the claim text.